Baillie Gifford & Co’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-92
| Closed | -$967 | – | 391 |
|
|
2023
Q1 | $967 | Hold |
92
| – | – | ﹤0.01% | 444 |
|
|
2022
Q4 | $3.11K | Hold |
92
| – | – | ﹤0.01% | 464 |
|
|
2022
Q3 | $4K | Hold |
92
| – | – | ﹤0.01% | 455 |
|
|
2022
Q2 | $5K | Hold |
92
| – | – | ﹤0.01% | 452 |
|
|
2022
Q1 | $7K | Hold |
92
| – | – | ﹤0.01% | 455 |
|
|
2021
Q4 | $19K | Hold |
92
| – | – | ﹤0.01% | 385 |
|
|
2021
Q3 | $25K | Sell |
92
-11
| -11% | -$2.99K | ﹤0.01% | 339 |
|
|
2021
Q2 | $26K | Hold |
103
| – | – | ﹤0.01% | 331 |
|
|
2021
Q1 | $31K | Buy |
103
+2
| +2% | +$602 | ﹤0.01% | 299 |
|
|
2020
Q4 | $26K | Buy |
+101
| New | +$26K | ﹤0.01% | 303 |
|